Hims & Hers Health falls after narrowing 2026 revenue forecast
HIMS•Hims & Hers Health narrowed its 2026 revenue forecast to $3.13 billion-$3.15 billion, below analysts’ $3.21 billion estimate. Third-quarter revenue of $890.4 million also missed estimates of $892.9 million.
1. Forecast narrowed
Hims & Hers Health shares fell 2.3% to $22.46 in extended trading after the company narrowed its 2026 revenue forecast to $3.13 billion-$3.15 billion from $3.1 billion-$3.3 billion. Analysts expect $3.21 billion. The company said gross margins contracted amid its expansion into branded weight-loss drugs and international markets.
2. Third-quarter revenue
The company reported third-quarter revenue of $890.4 million, below estimates of $892.9 million.
